000 | 01357 a2200349 4500 | ||
---|---|---|---|
005 | 20250517074845.0 | ||
264 | 0 | _c20161213 | |
008 | 201612s 0 0 eng d | ||
022 | _a1879-016X | ||
024 | 7 |
_a10.1016/j.pharmthera.2016.01.007 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMichel, Martin C | |
245 | 0 | 0 |
_aβ3-Adrenoceptor agonists for overactive bladder syndrome: Role of translational pharmacology in a repositioning clinical drug development project. _h[electronic resource] |
260 |
_bPharmacology & therapeutics _cMar 2016 |
||
300 |
_a66-82 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAdrenergic beta-3 Receptor Agonists _xpharmacology |
650 | 0 | 4 |
_aAdrenergic beta-3 Receptor Antagonists _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies _xpharmacology |
650 | 0 | 4 | _aDrug Repositioning |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLigands |
650 | 0 | 4 |
_aReceptors, Adrenergic, beta-3 _xgenetics |
650 | 0 | 4 | _aSyndrome |
650 | 0 | 4 | _aTranslational Research, Biomedical |
650 | 0 | 4 |
_aUrinary Bladder _xphysiology |
650 | 0 | 4 |
_aUrinary Bladder, Overactive _xdrug therapy |
700 | 1 | _aKorstanje, Cees | |
773 | 0 |
_tPharmacology & therapeutics _gvol. 159 _gp. 66-82 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pharmthera.2016.01.007 _zAvailable from publisher's website |
999 |
_c25666833 _d25666833 |